Background/Aims: Ischemia-reperfusion (I/R) injury is believed to be the major cause for detriments in coronary heart diseases, but few effective therapies for prevention or treatment of I/R injury are available. Gypenoside (GP) is the predominant effective component of Gynostemma pentaphyllum
Introduction
Coronary heart disease (CHD) is the major cause of death and disability worldwide [1, 2] . Based on WHO's investigation in 2012, more than 17.5 million non-communication diseases death is attributed to disorders related to CHD (http://www.who.int/gho/ncd/ mortality_morbidity/cvd/en/). Detriments of CHD are generally attributed to attack of the onset of coronary artery occlusion. Fortunately, developments in medical and coronary interventions have been achieved and contribute to the control of mortality rates of AMI. Currently, primary percutaneous coronary intervention (PPCI) and thrombolytic therapies are the most effective treatments for AMI. However, these treatment modalities are rendered less effective by them leading to further cardiomyocyte death known as ischemia-reperfusion (I/R) injury [3] [4] [5] . Contrary to the rapid development of PCI technology and antiplatelet agents, few means for prevention of myocardial I/R injury are available. With such potential clinical importance, therapies targeting myocardial I/R injury for further cardio-protection is imperative.
during the initial stage of reperfusion [10] . Based on such theory, numerous chemicals and therapeutic potential against I/R injury [11] [12] [13] [14] [15] [16] [17] [18] . Gynostemma pentaphyllum, also known as 'Jiaogulan', is a folk medicine and herbal tea in Asian countries. Gypenoside (GP) is the predominant effective component of Gynostemma pentaphyllum and has shown its potency capable of improving the cardiac function of myocardial ischemia mice [22, 23] . And the our knowledge, the effect of GP on myocardial I/R injury has not been proved, not to mention the underlying mechanism involved in the process.
Therefore, in the current study, the cardio-protective function of GP against myocardial I/R injury was investigated with a series in vitro and in vivo the mechanism related to the attenuating effect of GP on myocardial I/R injury, regulation apoptosis in cardiomyoctyes. Based on the investigation at molecular level, GP might take protective action on myocardial tissues via augmentation of PI3K/Akt pathway. 
H&E and TTC staining
The histological changes in ischemic penumbra part of heart tissue in different groups were observed area in the whole left ventricle of the heart of each sample were determined using 2,3,5-triphenyltetrazolium pale tissue was presumed to be infarcted. The percentages of infarcted area in each slice were measured using the Image-Pro Plus software.
TUNEL staining
2 O 2 for 10 min at room temperature to seal the samples to tissue samples, respectively.
Flow cytometry
apoptosis cell percentage) and the early apoptotic rate (LR, lower right quadrant-prophase apoptosis cell percentage).
Western blotting
with the membranes overnight at room temperature. After additional three washes, secondary antibodies (1:5000) were added and incubated with the membranes for 5 h. After another three washes, the blots
Statistical analysis
multiple comparisons were performed with Duncan method. All the statistical analyses were conducted
Results

Pre-administration of GP ameliorated the cardiac function and structure in I/R injured rat models
Detail data of hemodynamics parameters was shown in Table 1 and Table 2 . I/R injury 2), represent the chronic protection effect of GP against impairments induced by I/R injury as well.
The serum levels of LDH and CK in I/R group were higher than those in sham group, of GP, the levels of the two indicators were down-regulated in GP treated groups, and the P < 0.05).
were stained red. A comparison between sham and I/R group revealed severe injuries due to I/R. Pre-administration with GP before model establishment could alleviate the damage with most myocardial cells retaining their normal structure (Fig. 1A) . Table 1 . Pre-administration with GP improved the hemodynamics parameters and cardiac injury in model P group, P < 0.05 Table 2 . Chronic administration with GP improved the hemodynamics parameters and cardiac injury in model animals P < P < 0.05
The impact of preadministration of GP on the infarction area was shown in Fig. injury remarkably decreased the infarction area. Taken the above results together, although the infarction areas of GP-treated rats were still much larger than those in sham group, the result was indicative of the improvement of myocardial function and structure by GP (Fig. 1B) . Moreover, results of long-term assay showed that the infarction area in I/R+GPH group was group and the effect could be observed one week after I/R injury induction (Fig. 2) .
Pre-administration of GP signi icantly attenuated apoptosis via blockade of CHOP and activation of PI3K/Akt pathways in vivo
nuclei were observed in GP treated groups compared with sham group (Fig. 3A) . due to I/R treatment (P < 0.05).
To investigate the direct effect of GP on apoptosis in myocardial tissues, analyses of Table 3 . Detail IOD values and quantitative analysis results of western blotting assay in in vivo P P < 0.05. c, sig-P < 0.05 size and depression of myocardial function. Pre-condition of GP restored the production of the three proteins in myocardial tissues to a relatively normal level, and the effect was dosetreatment resulted in dramatic reduction in production of p-Akts and p-Akt/Akt ratios, whereas no apparent effect on the level of total Akt. In groups pre-administrated with GP, the phosphorylation of Akt and p-Akt/Akt ratios gradually returned to a relatively high level, and the effect was dose-dependent. In addition, activity of Akt was also represented Table 4 . Ratios of phosphorylated form amount to total amount in rat models after GP P < P GPL group, P P < 0.05 
Pre-administration of GP signi icantly attenuated ER stress and apoptosis in vitro
induced apoptosis in H9c2 cell lines (Fig. 5A) . Incubation with GP could relieve the injury that PI3K/Akt pathway participated in the inhibiting effect of GP on apoptosis in H9c2 cells.
on apoptotic rate (Fig. 5A) , and the differences between GP treated groups and inhibitor due to OGD/R treatment was increased by pre-treatment of GP; the up-regulation of GRP78, CHOP, cleaved Currently, the cornerstone of the treatment for AMI is the timely myocardial reperfusion [31] . However, reperfusion process can itself lead irreversible structure damage and function loss to heart, namely I/R injury. Although plenty of effort has been made to prevent or treat myocardial I/R injury in the recent years, little progress has been made. GP, the major active component of Gynostemma pentaphyllum, possesses capacities to antagonize liver hypothesized that GP could attenuate myocardial I/R injury via its anti-apoptotic function.
Both in in vivo and in vitro cell apoptotic rates. In in vivo induction, the effect of GP administration still persisted in model animals, representing the injury to cardiomyocytes, the levels of LDH and CK were also determined. Myocardial LDH level is an indicator of necrotic damage and increased CK levels has served as an indicator for myocardial injury for decades. Pre-condition with GP substantially down-regulated the tissues was decreased by GP treatment as well. Taken together, it was demonstrated that GP strongly protected cardiomyocytes against I/R injury.
I/R injury in that the disorder is primarily characterized by cardiomyocyte necrosis and plays a crucial role in I/R-induced cell dysfunction [3] . In the present study, up-regulation stress can induce cell apoptosis, and GRP78 is a key protein involved in the CHOP pathway [35] . Our data showed that levels of both molecules could be enhanced by I/R and OGD/R treatments. These molecules were proved to be the up-stream regulators of CHOP pathway on both its phosphorylation status and the total protein concentration. Generally, activation Table 6 .
in vitro -P P P GPM group, P P < 0.05
